UK markets closed

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2100+0.0400 (+3.42%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 35.91M
Enterprise value 31.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.90
Price/book (mrq)0.46
Enterprise value/revenue 1.68
Enterprise value/EBITDA -0.59

Trading information

Stock price history

Beta (5Y monthly) 1.53
52-week change 3-67.56%
S&P500 52-week change 318.96%
52-week high 33.8200
52-week low 30.6800
50-day moving average 31.3418
200-day moving average 31.6079

Share statistics

Avg vol (3-month) 3109.24k
Avg vol (10-day) 372.57k
Shares outstanding 529.92M
Implied shares outstanding 629.92M
Float 824.1M
% held by insiders 114.16%
% held by institutions 129.98%
Shares short (15 Jul 2024) 41.62M
Short ratio (15 Jul 2024) 419.56
Short % of float (15 Jul 2024) 46.04%
Short % of shares outstanding (15 Jul 2024) 45.40%
Shares short (prior month 14 Jun 2024) 41.49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Nov 2019
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -282.37%
Operating margin (ttm)-310.09%

Management effectiveness

Return on assets (ttm)-31.39%
Return on equity (ttm)-71.67%

Income statement

Revenue (ttm)19.05M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)-18.50%
Gross profit (ttm)N/A
EBITDA -56.41M
Net income avi to common (ttm)-49.35M
Diluted EPS (ttm)-1.6800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.37M
Total cash per share (mrq)1.15
Total debt (mrq)30.43M
Total debt/equity (mrq)39.00%
Current ratio (mrq)2.95
Book value per share (mrq)2.65

Cash flow statement

Operating cash flow (ttm)-38.73M
Levered free cash flow (ttm)-14.11M